CollPlant- When Medical
Innovation Meets ESG Action
CollPlant- When Medical Innovation Meets ESG Action
Based on our revolutionary, plant-based technology for the mass production of Type I recombinant human collagen (rhCollagen), we strive to deliver viable medical solutions that empower the betterment of humanity and environmental sustainability. Our company is propelled by an unwavering commitment to disruption and to transcending the boundaries of medical innovation to enable sustainable development.
Our Vision
Be the leaders in regenerative medicine, helping people live longer and better through our innovative collagen technology.
Our Mission
Discover, develop and deliver collagen technology and regenerative-medicine products to improve and prolong lives.
Our ESG Framework
CollPlant is dedicated to making a positive impact on the planet- from the environment and its people to communities and patients we ultimately serve.
Our rhCollagen production process, based on plant-based genetic engineering, minimizes the need for animal-derived collagen. This method not only reduces the environmental impact of traditional practices but also supports ethical and sustainable production.
Our ESG strategy is committed to sustainable business practices, prioritizing current and future societal and environmental needs while upholding ethical conduct.
Impact on People
We firmly believe a sustainable healthcare and medicine future begins with safer and healthier treatments, positively impacting patient safety, health, and quality of life.
Healthier and Safer Collagen
Derived from tobacco leaves with bio-functionality that leads to faster tissue repair and does not elicit an immune response.
Ensuring a Sustainable Quality of Life
Our 3D bioprinted breast implants offer a safer and regenerative alternative for augmentation and reconstruction. They are designed to provide long lasting performance, aim to reduce waste, and improving patients’ quality of life.
Solving Unmet Medical Needs
Our portfolio of rhCollagen-based Bioinks enables advanced biofabrication of functional tissue models for drug discovery and personalized medicine, offering a superior and ethical alternative to animal testing
while addressing unmet medical needs and driving innovation.
Establishing a Sustainable Demand for Tobacco Plants
Collagen production opens up new economic opportunities for regions historically reliant on tobacco farming. This initiative fosters economic growth and diversification.
Impact on People
We firmly believe a sustainable healthcare and medicine future begins with safer and healthier treatments, positively impacting patient safety, health, and quality of life.
Solving Unmet Medical Needs
By utilizing patient cells in our innovative gut tissue model technology, to enable personalized therapeutic response and drug screening for ulcerative colitis treatment. This approach addresses pressing unmet medical needs and drives innovation in less commonly prioritized medical conditions.
Healthier and Safer Collagen
Derived from tobacco leaves with bio-functionality that leads to faster tissue repair and does not elicit an immune response.
Ensuring a Sustainable Quality of Life
Our 3D bioprinted breast implants offer a safer and regenerative alternative for augmentation and reconstruction. They are designed to provide long lasting performance, aim to reduce waste, and improving patients’ quality of life.
Establishing a Sustainable Demand for Tobacco Plants
Collagen production opens up new economic opportunities for regions historically reliant on tobacco farming. This initiative fosters economic growth and diversification.
Impact on Business Conduct
We conduct our business according to corporate governance and high ethical standards, enabling innovation-driven medical progress through partnerships and a sustainable supply chain.
Our approach emphasizes ethical medical development, focusing on improving animal welfare in medical testing by adhering to the 3 Rs – Replacement, Reduction, and Refinement.
We minimize animal testing in preclinical trials using Finite Element Analysis (FEA), a simulation technique that assesses product design under real-world conditions, thereby reducing our reliance on animal trials.
Support for the United Nations’
Sustainable Development Goals (SDGs)
CollPlant joins the global efforts to support the United Nations’ Sustainable Development Goals
and has set out a commitment to furthering efforts to promote SDGs 3, 9, 12, and 17.
We have chosen to focus on those goals where we have the most significant potential impact and
that contribute to the growth of our business.
Goal | Description | Target | Our Contribution |
|---|---|---|---|
 | Good Health and Wellbeing: Ensure healthy lives and promote wellbeing for all at all ages
https://sdg-tracker.org/good-health | 3.8 – Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all. | CollPlant’s products and product candidates are designed to contribute to notable advancements in medical treatments and therapies, leading to improved health outcomes and wellbeing for individuals. |
 | Innovation and Infrastructure: Build resilient infrastructure, promote inclusive and sustainable industrialization, and foster innovation
https://sdg-tracker.org/infrastructure-industrialization | 9.5 – Enhance research and upgrade industrial technologies | CollPlant’s research, development, and manufacturing processes drive innovation and promote sustainable infrastructure |
 | Responsible Consumption: Ensure sustainable consumption and production patterns
https://sdg-tracker.org/sustainable-consumption-production | 12.2 – Sustainable management and use of natural resources
12.4 – Responsible management of chemicals and waste
12.5 – Substantially reduce waste generation | CollPlant’s development of plant-derived recombinant human collagen promotes sustainable and responsible production practices.
By utilizing natural resources efficiently and reducing waste, CollPlant contributes to more sustainable consumption and production patterns. |
 | Partnership for the Goals: Revitalize the global partnership for sustainable development | 17.6 – Knowledge sharing and cooperation for access to science, technology and innovation | CollPlant’s collaborations with academic institutions, research organizations, and commercial partners foster enhanced cooperation, expands access to science and technology, and promotes innovation in the field of regenerative medicine, improving coordination among myriad entities. |
Goal | | | | |
|---|---|---|---|---|
Description
| Good Health and Wellbeing: Ensure healthy lives and promote wellbeing for all at all ages
https://sdg-tracker.org/good-health | Innovation and Infrastructure: Build resilient infrastructure, promote inclusive and sustainable industrialization, and foster innovation
https://sdg-tracker.org/infrastructure-industrialization | Responsible Consumption: Ensure sustainable consumption and production patterns
https://sdg-tracker.org/sustainable-consumption-production | Partnership for the Goals: Revitalize the global partnership for sustainable development |
Target
| 3.8 – Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all. | 9.5 – Enhance research and upgrade industrial technologies | 12.2 – Sustainable management and use of natural resources
12.4 – Responsible management of chemicals and waste
12.5 – Substantially reduce waste generation | 17.6 – Knowledge sharing and cooperation for access to science, technology and innovation |
Our Contribution
| CollPlant’s products and product candidates are designed to contribute to notable advancements in medical treatments and therapies, leading to improved health outcomes and wellbeing for individuals. | CollPlant’s research, development, and manufacturing processes drive innovation and promote sustainable infrastructure | CollPlant’s development of plant-derived recombinant human collagen promotes sustainable and responsible production practices.
By utilizing natural resources efficiently and reducing waste, CollPlant contributes to more sustainable consumption and production patterns. | CollPlant’s collaborations with academic institutions, research organizations, and commercial partners foster enhanced cooperation, expands access to science and technology, and promotes innovation in the field of regenerative medicine, improving coordination among myriad entities. |
Aligned with the
UN Global Compact
As of September 2023, CollPlant is an official signatory of the UN Global Compact.
CollPlant is committed to the Ten Principles of the United Nations Global Compact, which includes our promise to treat all workers with respect and dignity, ensure safe working conditions, and conduct environmentally responsible, ethical operations.
The UN Global Compact is a voluntary initiative that encourages businesses and organizations to align their strategies and operations with ten universally accepted principles in the areas of human rights, labor, environment, and anti-corruption.